Skip to main content

Skin Quality

1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

AbbVie
AbbVieNORTH CHICAGO, IL
1 program
1
Hyper-Diluted BotoxPhase 21 trial
Active Trials
NCT03097835Completed15Est. Jul 2018
Fitzpatrick Company
Fitzpatrick CompanyON - Waterloo
1 program
1064NM pico LaserN/A1 trial
Active Trials
NCT05595525Unknown20Est. Jun 2023
KiOmed Pharma
KiOmed PharmaBelgium - Liège
1 program
KIO015N/A1 trial
Active Trials
NCT05747690Completed78Est. May 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AbbVieHyper-Diluted Botox
KiOmed PharmaKIO015
Fitzpatrick Company1064NM pico Laser

Clinical Trials (3)

Total enrollment: 113 patients across 3 trials

NCT03097835AbbVieHyper-Diluted Botox

Evaluation of Skin Quality Improvement

Start: Feb 2018Est. completion: Jul 201815 patients
Phase 2Completed

Evaluation of Performance and Safety of KIO015 in Face Tissue Filling

Start: Jan 2023Est. completion: May 202478 patients
N/ACompleted

Laser Treatment to Improve Skin Quality

Start: Nov 2022Est. completion: Jun 202320 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.